Firebrick Pharma Limited (ASX: FRE)
Health Care · Pharmaceuticals · AU
AU$0.03
+7.69% today · -58.8% 1Y
Firebrick Pharma Limited (ASX: FRE) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $5.57M and employs 6 people.
Over the last twelve months the share price has lost 58.8%, trading between 0.02 and 0.07.
Tweenvest scores Firebrick Pharma Limited across four factors: quality 37/100, value 30/100. Its strongest factor is quality.
FRE price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $5.57M
- Revenue (TTM)
- $93.82K
- P/E
- —
- EPS
- -0.01
- Dividend yield
- —
- Beta (5Y)
- 0.90
- 52-week high
- AU$0.07
- 52-week low
- AU$0.02
- Avg volume (3M)
- —
- Shares outstanding
- 287.20M
- Employees
- 6
- Next earnings
- —
About Firebrick Pharma Limited
Firebrick Pharma Limited, an enterprise established in 2012 and headquartered in Melbourne, Australia, is dedicated to the research, development, and market launch of Nasodine, a nasal spray treatment for the common cold, exclusively for the Australian market.
- ISIN
- AU0000197352
- Founded
- 2012
- Listed since
- Jan 27, 2022
- Exchange
- Australian Securities Exchange
- Currency
- AUD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Invex Therapeutics LtdASX: IXC | $5.81M | AU$0.11 | -4.35% |
| Rekvina Laboratories LimitedBSE: 526075 | $5.76M | Rs49.86 | -0.08% |
| Pulmatrix, Inc.NasdaqCM: PULM | $5.73M | $1.49 | -5.10% |
| Stenocare A/SCPSE: STENO | $5.66M | Dkr0.78 | -10.57% |
| Lamdong Pharmaceutical Joint Stock CompanyHNX: LDP | $5.55M | ₫7,700.00 | -1.28% |
| Avant Brands Inc.TSX: AVNT | $5.50M | CA$0.53 | +3.92% |
| ANG Lifesciences India LimitedBSE: 540694 | $5.45M | Rs40.18 | -0.22% |
| Glow Lifetech Corp.CNSX: GLOW | $5.40M | CA$0.04 | -11.11% |
Figures last refreshed Oct 4, 2026.